DrugPatentWatch Database Preview
BREVIBLOC IN PLASTIC CONTAINER Drug Profile
see a sample report or, see our see our flat-rate plans
When do Brevibloc In Plastic Container patents expire, and when can generic versions of Brevibloc In Plastic Container launch?
Brevibloc In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA. There are two patents protecting this drug.
The generic ingredient in BREVIBLOC IN PLASTIC CONTAINER is esmolol hydrochloride. There are eight drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the esmolol hydrochloride profile page.
Summary for BREVIBLOC IN PLASTIC CONTAINER
| US Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 5 |
| Bulk Api Vendors: | 60 |
| Clinical Trials: | 12 |
| Patent Applications: | 560 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | BREVIBLOC IN PLASTIC CONTAINER at DailyMed |
Pharmacology for BREVIBLOC IN PLASTIC CONTAINER
| Drug Class | beta-Adrenergic Blocker |
| Mechanism of Action | Adrenergic beta-Antagonists |
Synonyms for BREVIBLOC IN PLASTIC CONTAINER
| (+-)-Methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate hydrochloride |
| (+/-)-methyl p-[2-hydroxy-3-(isopropylamino) propoxy]hydrocinnamate hydrochloride |
| 4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoic acid methyl ester HCl |
| 4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benxzenepropanoic Acid Methyl Ester Hydrochloride |
| 4-[2-HYDROXY-3-[(1-METHYLETHYL)AMINO]PROPOXY]BENZENEPROPANOIC ACID METHYL ESTER HYDROCHLORIDE |
| 4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzenepropanoic acid methyl ester hydrochloride hydrochloride |
| 598E034 |
| 81147-92-4 (Parent) |
| 81161-17-3 |
| 81161-17-3, 81147-92-4(free base) |
| AB0013228 |
| AB07716 |
| AC-6972 |
| AC1L2XGQ |
| AC1Q3EA6 |
| AKOS015895316 |
| AN-9460 |
| API0001758 |
| Asl 8052 |
| ASL-8052 |
| Benzenepropanoic acid, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, methyl ester, hydrochloride |
| Benzenepropanoic acid, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, methyl ester, hydrochloride, (+-)- |
| Benzenepropanoic acid, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, methyl ester,hydrochloride |
| BG0502 |
| Brevibloc |
| Brevibloc (TN) |
| Brevibloc Double Strength in plastic container |
| C16H25NO4.HCl |
| CAS-81161-17-3 |
| CCG-100972 |
| CCG-220890 |
| CHEBI:4857 |
| CHEMBL1201115 |
| CPD000469141 |
| CS-4908 |
| CTK8F9497 |
| D00644 |
| DSSTox_CID_28929 |
| DSSTox_GSID_49003 |
| DSSTox_RID_83195 |
| DTXSID7049003 |
| EBD13377 |
| Esmolol (hydrochloride) |
| Esmolol HCL |
| Esmolol hydrochloride |
| Esmolol hydrochloride (JAN/USAN) |
| Esmolol hydrochloride [USAN] |
| Esmolol hydrochloride, >=98% (HPLC), solid |
| Esmolol hydrochloride, United States Pharmacopeia (USP) Reference Standard |
| Esmolol(hydrochloride) |
| Esmololhydrochloride |
| FT-0082446 |
| FT-0601541 |
| H746 |
| HSDB 6530 |
| HY-B1392 |
| I06-0682 |
| J-003862 |
| KS-00001FBX |
| KS-1353 |
| LS-31122 |
| methyl 3-(4-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)propanoate hydrochloride |
| METHYL 3-(4-[2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY]PHENYL)PROPANOATE HYDROCHLORIDE |
| methyl 3-(4-{2-hydroxy-3-[(methylethyl)amino]propoxy}phenyl)propanoate, chlori de |
| METHYL 3-[4-(2-HYDROXY-3-PROPAN-2-YLAMINO-PROPOXY)PHENYL]PROPANOATE HYDROCHLORIDE |
| Methyl 3-[4-(2-hydroxy-3-propan-2-ylamino-propoxy)phenyl]propanoate hydrochloride; Brevibloc |
| methyl 3-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]propanoate hydrochloride |
| methyl 3-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]propanoate hydrochloride |
| Methyl 3-{4-[2-Hydroxy-3-(isopropylamino)propoxy]phenyl}propanoate hydrochloride (Esmolol HCl) |
| MLS001401393 |
| MolPort-003-847-093 |
| NC00222 |
| NCGC00185766-01 |
| NCGC00185766-04 |
| OR161498 |
| Q-201070 |
| s4100 |
| SAM001246533 |
| SBB055181 |
| SCHEMBL41086 |
| SMR000469141 |
| TL8005428 |
| Tox21_113496 |
| Tox21_113496_1 |
| W-1240 |
US Patents and Regulatory Information for BREVIBLOC IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | BREVIBLOC IN PLASTIC CONTAINER | esmolol hydrochloride | INJECTABLE;INJECTION | 019386-004 | Feb 16, 2001 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Baxter Hlthcare | BREVIBLOC IN PLASTIC CONTAINER | esmolol hydrochloride | INJECTABLE;INJECTION | 019386-004 | Feb 16, 2001 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
Expired US Patents for BREVIBLOC IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | BREVIBLOC IN PLASTIC CONTAINER | esmolol hydrochloride | INJECTABLE;INJECTION | 019386-004 | Feb 16, 2001 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
see a sample report or, see our see our flat-rate plans
